Vitrakvi Coupons & Savings Card – Discount Prices from $21034.54
My prescription
Edit
100MG, Vitrakvi (30 Capsules)
Select pharmacy
Walgreens
$21034.54
COUPON PRICEVitrakvi savings card
Show this card to your pharmacistWalgreens
$21034.54
BIN
ID
PCN
GRP
019876
LH6062177B
CHIPPO
LHX
Powered by
Related kinase inhibitors prescriptions
Related kinase inhibitors prescriptions
Price history for Vitrakvi
30 Capsules, 100MG
Average retail price for Vitrakvi
Average SaveHealth price for Vitrakvi
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Vitrakvi dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 25MG | 30 Capsules | $7005.97 | $233.53 |
| 100MG | 30 Capsules | $21034.54 | $701.15 |
Vitrakvi Warnings
When considering treatment with Vitrakvi, it's important to be aware of certain risks associated with its use:
Central Nervous System (CNS) Effects: Vitrakvi may cause issues such as dizziness, confusion, problems with concentration, attention, and memory, mood changes, and sleep disturbances. Patients should inform their healthcare provider if they experience any of these symptoms or if they worsen. It's advisable to avoid driving or operating heavy machinery until it's clear how Vitrakvi affects you.
Bone Fractures: There is a risk of bone fractures while taking Vitrakvi. Patients should report any new or unusual bone pain, changes in mobility, or bone abnormalities to their healthcare provider promptly.
Liver Problems: Vitrakvi can lead to abnormal liver blood tests, which may sometimes become serious. Healthcare providers will conduct liver function tests before starting treatment and periodically during therapy. Patients should immediately report symptoms such as yellowing of the skin or eyes, dark urine, pain in the upper right side of the abdomen, unusual bruising or bleeding, fatigue, nausea, vomiting, or loss of appetite.
Embryo-Fetal Toxicity: Vitrakvi can harm an unborn baby. Women who are pregnant or plan to become pregnant should inform their healthcare provider. Effective contraception should be used during treatment and for one week after the last dose. Men with female partners who can become pregnant should also use effective contraception during treatment and for one week after the last dose.
Breastfeeding: It is not known if Vitrakvi passes into breast milk. Women should not breastfeed during treatment and for one week after the final dose.
Patients should discuss these risks with their healthcare provider to ensure Vitrakvi is appropriate for their individual health circumstances.
Vitrakvi Side Effects
When taking this medication, you might experience some mild side effects such as tiredness, dizziness, cough, constipation, swelling of the ankles, feet, or hands, nausea, or vomiting. Although these symptoms are common, they often do not lead to serious problems. To help manage nausea and vomiting, consider eating small meals, avoiding eating right before treatment, or limiting your activity. If these side effects persist or worsen, it's important to inform your healthcare provider. There are also some serious side effects to be aware of. These include signs of liver problems like persistent nausea or vomiting, loss of appetite, stomach or abdominal pain, yellowing of the eyes or skin, or dark urine. Other serious effects can involve numbness or tingling in the limbs, changes in mood or mental state such as confusion, depression, anxiety, or memory loss, as well as difficulty sleeping, speaking, walking, bone pain, or easily broken bones. If you encounter any of these, seek medical advice immediately. While a severe allergic reaction to this medication is rare, it is crucial to get medical attention right away if you experience symptoms such as rash, itching or swelling (particularly of the face, tongue, or throat), severe dizziness, or difficulty breathing. Always communicate with your healthcare provider about any other side effects you may notice.
Vitrakvi Interactions
What cancer is Vitrakvi for?
Vitrakvi (larotrectinib) is used for the treatment of solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion. It is not specific to a particular type of cancer but is used for tumors with this specific genetic feature, regardless of the tumor's location in the body.
How much does Vitrakvi cost?
The cost of Vitrakvi (larotrectinib) can vary significantly based on factors such as insurance coverage, pharmacy location, and dosage. Without insurance, the price can be quite high, often exceeding several thousand dollars for a month's supply. Patients are encouraged to check with their insurance provider for coverage details and explore patient assistance programs offered by the manufacturer to potentially reduce out-of-pocket expenses.
Is Vitrakvi covered by Medicare?
Coverage for Vitrakvi (larotrectinib) under Medicare can vary depending on the specific Medicare plan. Generally, Medicare Part D or Medicare Advantage plans with prescription drug coverage may cover Vitrakvi. It is important for individuals to check with their specific plan provider to confirm coverage details, including any prior authorization requirements or out-of-pocket costs.
How does Vitrakvi work?
Vitrakvi, also known as larotrectinib, works by targeting and inhibiting a specific protein called TRK (tropomyosin receptor kinase). This protein is involved in the growth and survival of cancer cells. Vitrakvi is designed to block the activity of TRK, thereby preventing the cancer cells from growing and spreading. It is used to treat solid tumors that have a specific genetic alteration known as an NTRK gene fusion, regardless of the tumor's location in the body.
How much is Vitrakvi in the US?
The cost of Vitrakvi (larotrectinib) in the United States can vary depending on factors such as insurance coverage, pharmacy, and location. As of the latest information, the list price for Vitrakvi can be quite high, often exceeding several thousand dollars for a month's supply. Patients are encouraged to check with their insurance provider and pharmacy for specific pricing and potential financial assistance programs that may be available.